However, when β-catenin expression was suppressed using an inhibitor XAV 939, cardiac hypertrophy associated transcription factor NFATc3 and hypertrophy marker BNP were also downregulated (Figure 1B). Here, NFATC3 is linked to cardiac hypertrophy.